These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 11168685)

  • 21. The prognostic value of p53 nuclear overexpression and MIB-1 as a proliferative marker in transitional cell carcinoma of the bladder.
    Popov Z; Hoznek A; Colombel M; Bastuji-Garin S; Lefrere-Belda MA; Bellot J; Abboh CC; Mazerolles C; Chopin DK
    Cancer; 1997 Oct; 80(8):1472-81. PubMed ID: 9338472
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Apoptotic cell death and Smad4 expression in transitional cell carcinoma of the renal pelvis and ureter.
    Kong C; Zhang X; Takenaka I
    Int J Urol; 2001 Jul; 8(7):386-90. PubMed ID: 11442661
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic significance of cyclin E and p53 protein overexpression in carcinoma of the renal pelvis and ureter.
    Furihata M; Ohtsuki Y; Sonobe H; Shuin T; Yamamoto A; Terao N; Kuwahara M
    Br J Cancer; 1998 Mar; 77(5):783-8. PubMed ID: 9514058
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic significance of p53, bcl-2 and Ki-67 in high risk superficial bladder cancer.
    Stavropoulos NE; Filiadis I; Ioachim E; Hastazeris K; Tsimaris I; Kalogeras D; Stefanaki S; Agnantis NJ
    Anticancer Res; 2002; 22(6B):3759-64. PubMed ID: 12552989
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transitional cell carcinoma of the renal pelvis and ureter: prognostic relevance of nuclear deoxyribonucleic acid ploidy studied by slide cytometry: an 8-year survival time study.
    al-Abadi H; Nagel R
    J Urol; 1992 Jul; 148(1):31-7. PubMed ID: 1613875
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic significance of Ki-67 labeling index in urothelial tumors of the renal pelvis and ureter.
    Masuda M; Iki M; Takano Y; Asakura T; Noguchi S; Ikeda I; Kubota Y; Hosaka M
    J Urol; 1996 Jun; 155(6):1877-80; discussion 1880-1. PubMed ID: 8618278
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ki-67 MIB1 labelling index and the prognosis of primary TaT1 urothelial cell carcinoma of the bladder.
    Quintero A; Alvarez-Kindelan J; Luque RJ; Gonzalez-Campora R; Requena MJ; Montironi R; Lopez-Beltran A
    J Clin Pathol; 2006 Jan; 59(1):83-8. PubMed ID: 16394286
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Apoptosis in transitional cell carcinoma of the renal pelvis and ureter: association with proliferative activity, bcl-2 expression and prognosis.
    Masuda M; Takano Y; Iki M; Asakura T; Hashiba T; Noguchi S; Hosaka M
    J Urol; 1997 Sep; 158(3 Pt 1):750-3. PubMed ID: 9258073
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Prognostic implication of morphometric stromal parameters of renal pelvis and ureteral transitional cell carcinomas].
    Al'-Shukri CKh; Rybakova MG; Makovskaia AI; Tiurin AG; Kozlov VV; Ageev MN; Korneev IA
    Urologiia; 2004; (3):10-4. PubMed ID: 15199806
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lymphovascular invasion and pT stage are prognostic factors in patients treated with radical nephroureterectomy for localized upper urinary tract transitional cell carcinoma.
    Kim DS; Lee YH; Cho KS; Cho NH; Chung BH; Hong SJ
    Urology; 2010 Feb; 75(2):328-32. PubMed ID: 20018349
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The prognostic value of KI-67 proliferation index in transitional cell carcinoma of renal pelvis and ureter].
    Korneev IA
    Vopr Onkol; 2005; 51(2):211-5. PubMed ID: 16223003
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of proliferative markers Ki-67 (MIB-1) and proliferating cell nuclear antigen (PC10) in transitional cell carcinoma of the renal pelvis.
    Cheville JC; Terrell RB; Cohen MB
    Mod Pathol; 1994 Sep; 7(7):794-800. PubMed ID: 7824516
    [TBL] [Abstract][Full Text] [Related]  

  • 33. P53 and MDM2 Over-expression and Five-year Survival of Kidney Cancer Patients Undergoing Radical Nephrectomy--Iranian Experience.
    Abolhasani M; Salarinejad S; Asgari M
    Asian Pac J Cancer Prev; 2015; 16(12):5043-7. PubMed ID: 26163638
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of regulatory proteins and proliferative activity in relation to phenotypic characteristics of upper urothelial carcinoma.
    Dolićanin Z; Velicković LJ; Djordjević B; Visnjić M; Pesić I; Ristić A; Marjanović V
    Vojnosanit Pregl; 2011 Jul; 68(7):567-74. PubMed ID: 21899177
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection of p53 and bcl-2 protein in carcinoma of the renal pelvis and ureter including dysplasia.
    Furihata M; Sonobe H; Ohtsuki Y; Yamashita M; Morioka M; Yamamoto A; Terao N; Kuwahara M; Fujisaki N
    J Pathol; 1996 Feb; 178(2):133-9. PubMed ID: 8683378
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Pathological prognostic factors of renal pelvic and ureteral cancer].
    Kumano M; Furukawa J; Yamanaka K; Tanaka K; Yamada Y; Hara I; Fujisawa M
    Nihon Hinyokika Gakkai Zasshi; 2006 Sep; 97(6):786-90. PubMed ID: 17025211
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The impact of tumor location on prognosis of transitional cell carcinoma of the upper urinary tract.
    Park S; Hong B; Kim CS; Ahn H
    J Urol; 2004 Feb; 171(2 Pt 1):621-5. PubMed ID: 14713773
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bilharzial related, organ confined, muscle invasive bladder cancer: prognostic value of apoptosis markers, proliferation markers, p53, E-cadherin, epidermal growth factor receptor and c-erbB-2.
    Haitel A; Posch B; El-Baz M; Mokhtar AA; Susani M; Ghoneim MA; Marberger M
    J Urol; 2001 May; 165(5):1481-7. PubMed ID: 11342901
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alterations affecting the p53 control pathway in bilharzial-related bladder cancer.
    Osman I; Scher HI; Zhang ZF; Pellicer I; Hamza R; Eissa S; Khaled H; Cordon-Cardo C
    Clin Cancer Res; 1997 Apr; 3(4):531-6. PubMed ID: 9815716
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tissue microarray analysis of the prognostic value of E-cadherin, Ki67, p53, p27, survivin and MSH2 expression in upper urinary tract transitional cell carcinoma.
    Fromont G; Rouprêt M; Amira N; Sibony M; Vallancien G; Validire P; Cussenot O
    Eur Urol; 2005 Nov; 48(5):764-70. PubMed ID: 16126329
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.